Skip to main content
. 2019 May 27;37(9):1155–1163. doi: 10.1007/s40273-019-00810-8

Table 2.

Hypothetical cost-effectiveness model 0% discounting

Incremental costs (€) Incremental QALYs
New treatment 58,432.00 1.8572
Standard of care 10,445.00 1.0976
Incremental 47,987.00 0.7596
ICER €63,176.53

ICER incremental cost-effectiveness ratio, QALYs quality-adjusted life-years